This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Keytruda
  • /
  • Study of pomalidomide and low dose dexamethasone w...
Clinical trial

Study of pomalidomide and low dose dexamethasone with or without pembrolizumab (MK-3475) in refractory or relapsed and refractory multiple myeloma (rrMM) (MK-3475-183/KEYNOTE-183)

Read time: 2 mins
Last updated:19th Oct 2015
Identifier: NCT02576977
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest